TY - JOUR
T1 - Cost-effectiveness of increasing access to contraception during the Zika virus outbreak, Puerto Rico, 2016
AU - Li, Rui
AU - Simmons, Katharine B.
AU - Bertolli, Jeanne
AU - Rivera-Garcia, Brenda
AU - Cox, Shanna
AU - Romero, Lisa
AU - Koonin, Lisa M.
AU - Valencia-Prado, Miguel
AU - Bracero, Nabal
AU - Jamieson, Denise J.
AU - Barfield, Wanda
AU - Moore, Cynthia A.
AU - Mai, Cara T.
AU - Korhonen, Lauren C.
AU - Frey, Meghan T.
AU - Perez-Padilla, Janice
AU - Torres-Muñoz, Ricardo
AU - Grosse, Scott D.
N1 - Publisher Copyright:
© 2017, Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2017/1
Y1 - 2017/1
N2 - We modeled the potential cost-effectiveness of increasing access to contraception in Puerto Rico during a Zika virus outbreak. The intervention is projected to cost an additional $33.5 million in family planning services and is likely to be cost-saving for the healthcare system overall. It could reduce Zika virus-related costs by $65.2 million ($2.8 million from less Zika virus testing and monitoring and $62.3 million from avoided costs of Zika virus-associated microcephaly [ZAM]). The estimates are influenced by the contraception methods used, the frequency of ZAM, and the lifetime incremental cost of ZAM. Accounting for unwanted pregnancies that are prevented, irrespective of Zika virus infection, an additional $40.4 million in medical costs would be avoided through the intervention. Increasing contraceptive access for women who want to delay or avoid pregnancy in Puerto Rico during a Zika virus outbreak can substantially reduce the number of cases of ZAM and healthcare costs.
AB - We modeled the potential cost-effectiveness of increasing access to contraception in Puerto Rico during a Zika virus outbreak. The intervention is projected to cost an additional $33.5 million in family planning services and is likely to be cost-saving for the healthcare system overall. It could reduce Zika virus-related costs by $65.2 million ($2.8 million from less Zika virus testing and monitoring and $62.3 million from avoided costs of Zika virus-associated microcephaly [ZAM]). The estimates are influenced by the contraception methods used, the frequency of ZAM, and the lifetime incremental cost of ZAM. Accounting for unwanted pregnancies that are prevented, irrespective of Zika virus infection, an additional $40.4 million in medical costs would be avoided through the intervention. Increasing contraceptive access for women who want to delay or avoid pregnancy in Puerto Rico during a Zika virus outbreak can substantially reduce the number of cases of ZAM and healthcare costs.
UR - http://www.scopus.com/inward/record.url?scp=85006345752&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85006345752&partnerID=8YFLogxK
U2 - 10.3201/eid2301.161322
DO - 10.3201/eid2301.161322
M3 - Article
C2 - 27805547
AN - SCOPUS:85006345752
SN - 1080-6040
VL - 23
SP - 74
EP - 82
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 1
ER -